Nabla’s Post

Approximately 20 million children in the U.S. do not have full access to essential health services. It’s time to end that. 📒 DiMe is launching a multistakeholder effort to create The Playbook: Pediatric Digital Medicine this fall. The Playbook: Pediatric Digital Medicine will define the market opportunity for pediatric digital medicine products, best practices for their development and deployment, and address the unique ethical considerations accompanying children's use of digital medicine products. This project builds upon the success of The Playbook: Digital Clinical Measures and The Playbook: Digital Healthcare. The Playbooks are signature DiMe resources, providing essential guides supporting healthcare's most critical digital innovation efforts. 💡 Ready to be a part of this transformative journey? Dive into our mission. Join us today: https://bit.ly/3pcMpej

Change is difficult/hard/uncomfortable but not impossible.

"The first batch of FLCCC “senior fellows” consists of quacks and antivaxxers. But what will these fellows do? The whole thing seems to be part of a leadership reorganization in the FLCCC: This announcement comes on the heels of last week’s press release announcing that four of the other founding FLCCC physician/scientists have stepped into expanded leadership roles pursuant to the organization’s new strategic plan. “The FLCCC’s strategic growth plan process began more than six months ago, initiated by the formation of an executive committee comprising three of the FLCCC’s five independent directors — those who possess significant entrepreneurial and public company organizational leadership experience,” said Kelly Bumann, executive director. “This committee began serving last fall as the FLCCC’s ‘ad-hoc CEO’ in order to marshal the management team and all organizational resources to collaboratively develop a high-impact expansion and growth plan. The committee will continue to partner with the FLCCC’s executive management team and staff to execute the plan over the next several months.” Why? Apparently Dr. Kory is transferring his responsibility running the FLCCC to Dr. Joseph Varon and being kicked up to an “emeritus” status in the FLCCC because wants to expand his private grift: Dr. Pierre Kory is finalizing the transition of his responsibilities to Dr. Varon over the next 45 days. With the full encouragement and support of the FLCCC Alliance, Dr. Kory is shifting his primary focus to his rapidly growing private practice, Leading Edge Clinic, which is focused on the care of a growing number of patients suffering from vaccine-related injuries. In addition, he plans to devote more time to writing for his Substack blog at https://lnkd.in/gxxEMNNd while also continuing his efforts as a powerful spokesman through his international advocacy work. Just remember that it’s all about the grift; well, that and using legal thuggery to try to silence young physicians who expose the grift, like Dr. Alison Neitzel. There’s only one primary reason that the FLCCC is doing this, to give the appearance of medical and scientific legitimacy to their PPO. Will it work? It doesn’t need to convince actual physicians and scientists; it just needs to convince the lay public. Sadly, it might succeed."

It’s that time! Took my Pediatric Rehabilitation Medicine Board recertification. It has been 10 years since the last time. Medical and surgical specialties work through various certification processes to identify those with explertise in an area. The idea is to have a way of identifying who is of a standard. In practice, the process of Board certification is onerous and expensive without data showing test performance = clinical quality. There have been movements to get the ABMS affiliated Boards to re-think this. But once they quit issuing “lifetime” certification, we have been wedded to a process that ultimately determines our ability to work.

Given the breadth of diverse practice models available to IRs—from hospital-employed, private practice, IR within a DR group and outpatient-based labs—there are a few tenets to keep in mind when developing a new practice. Get the insight you need from this IR Quarterly article by Neal Khurana, MD, and comment what helped you when you developed your practice. https://brnw.ch/21wDzfI

Meet Dr. Amy Hajari Case, our Senior Medical Advisor for Education and Awareness! This March for Women’s History Month, let’s shine a spotlight on the women of the PFF Medical Team. === 🔹 What is your title? Director, ILD Program, Piedmont Healthcare - and - Senior Medical Advisor for Education and Awareness, PFF 🔹 What inspired you to become a pulmonologist? When I was a resident in internal medicine, I really enjoyed critical care medicine, which led me to pursue a fellowship in pulmonary and critical care medicine, because in most programs the training is combined. The more exposure I had to pulmonary medicine, I found that I also liked taking care of patients with pulmonary illnesses, from acute problems like pneumonia and pulmonary embolism, to chronic ones like pulmonary fibrosis. 🔹 Can you share a particularly rewarding or impactful moment in your career that stands out to you? I had an incredibly supportive mentor in fellowship, Dr. Joao de Andrade, who not only taught me how to care for patients with PF, but he also taught me a lot about clinical trials and what it takes to run an ILD program. Over a decade later, I still call on him when I need advice! 🔹 If you could share one piece of advice to the PF community, what would it be? Remember: you are not alone. There are lots of ways to find community, including support groups, pulmonary rehabilitation, and volunteering. Being diagnosed with PF can be scary, but there's someone out there who knows the road you're walking — just reach out so you can find them!

Have you heard about our new project? Digital Medicine Society (DiMe) and Boston Children's Hospital are leading a multistakeholder project to create The Playbook: Pediatric Digital Medicine to understand the barriers to product development and adoption of #pediatricdigitalmedicine. This project will push the boundaries of what’s possible in children’s health. Children face significant gaps in care and are among the last to benefit from advancements in the digitization of healthcare. The project team prioritizes closing this disparity and improving children’s lives through #equitable access to technological advancements that center on children’s unique needs and deliver ethical, effective, equitable, and safe care. The Playbook: Pediatric Digital Medicine will address the pressing need for ongoing advancement and care optimization for children. It will: Provide a comprehensive guide to advance digital solutions with long-term financial viability to improve the lives of every child  Define the market opportunity for pediatric digital medicine products, establish best practices for product development and deployment Address the unique ethical considerations accompanying children's use of digital medicine products Learn more about the project here: https://lnkd.in/eMuPqsXX

With an impact factor of 4.1 in 2022, Pediatric Critical Care Medicine now ranks 13th (increased from 14th) in the critical care medicine category of the 2023 Clarivate Analytics’ Journal Citation Reports. Thank you to the authors, reviewers, and editorial boards for their contributions and dedication to ensuring PCCM remains a trusted source for pediatric critical care content! Check out PCCM’s top-cited articles: pccmjournal.org #PedsICU #SCCMSoMe

Once again, awesome work by Lorri Zipperer curating the weekly AHRQ PSNet Weekly Resource (https://lnkd.in/dRp8VaiM). I just spent a good part of my day on the following articles: Identifying and classifying diagnostic errors in acute care across hospitals: early lessons from the Utility of Predictive Systems in Diagnostic Errors (UPSIDE) study. (https://lnkd.in/dS_xMbPK) Evaluating independent double checks in the pediatric intensive care unit: a human factors engineering approach. (https://lnkd.in/djrRRGid) Disparities in diagnostic timeliness and outcomes of pediatric appendicitis. (https://lnkd.in/diPd27qA) and What kinds of insights do Safety-I and Safety-II approaches provide? A critical reflection on the use of SHERPA and FRAM in healthcare. (https://lnkd.in/dZ5FmUYn) Also grateful for the mention of the SIDM PFAC Toolkit for Exploring Diagnostic Quality (https://lnkd.in/diZQznKv) 😀

Interesting talk on the pediatric challenges for medical devices tomorrow at 3:00PM (Eastern Standard Time) at the UCSF (remote link in the article) The challenges of developing pediatric medical devices are complex. With very few FDA-approved or cleared devices, clinicians are often forced to improvise, either by using adult-sized devices or outdated technology. This can lead to poorer outcomes for children, and a lack of safety and effectiveness data on the devices that are frequently used for pediatric care. This CERSI talk will focus on the regulatory challenges facing pediatric medical devices. The potential efficiencies of an adaptive platform trial which could save significant time and money relative to conventional trials will be explored. The financial barriers facing pediatric device development will be discussed and a brainstorming session of potential market and non-market (policy) based solutions that may address the market failure will follow. Lastly, the problem of racial bias in FDA-approved pulse oximeters and the challenges of conducting clinical trials involving pediatric medical devices in vulnerable populations will be discussed. Don't miss this exciting CERSI talk which will discuss the current state of pediatric medical device development and explore potential solutions to the complex regulatory challenges. #PediatricMedicalDevices #FDA #AdaptivePlatformTrials